Cellyan Biotechnology Co. Ltd (HKPD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cellyan Biotechnology Co. Ltd, updated every trading day.
Health Care · Other Pharmaceuticals
Price
$2.18
+1.87% today
Market cap
$5M
Overall quality
—
Kronos AI 30-day
+167.8%
8 of 8 simulated paths end higher
Cellyan Biotechnology Co. Ltd (HKPD) is a Health Care company in Other Pharmaceuticals, worth $5M. It trades at $2.18, up 1.87% today. Kronos AI's 30-day forecast is +167.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $5.73 (+167.8%) |
| Likely range | +136.9% … +229.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Other Pharmaceuticals
For information only, not investment advice. Prices updated: 2026-10-29.